TASE:ALMA
TASE:ALMAReal Estate

Almogim Holdings (TASE:ALMA) Net Profit Margin Hits 2.3%, Challenging Bearish Profitability Narratives

Almogim Holdings (TASE:ALMA) just posted its Q3 2025 results, reporting revenue of 80.4 million ILS and basic EPS of 0.04 ILS. Looking back, the company has seen revenue climb from 53.6 million ILS a year ago in Q2 2024, while EPS over that same period moved from 0.02 ILS to 0.04 ILS. Margins came under the spotlight this quarter as investors weighed the numbers against historical trends. See our full analysis for Almogim Holdings. Now let’s see how these fresh numbers stack up against the...
TASE:BLSR
TASE:BLSRReal Estate

Blue Square Real Estate (TASE:BLSR) Net Profit Margin Boosted by One-Off Gain, Testing Sustainability Narratives

Blue Square Real Estate (TASE:BLSR) just published its Q3 2025 results, posting total revenue of ₪154.56 million and basic EPS of ₪24.99. For historical context, over the past six quarters, revenue has ranged from ₪150.89 million to ₪366.10 million, while EPS has tracked between ₪6.37 and ₪24.99. Margins remain a key focal point for investors as they weigh the implications of these current results. See our full analysis for Blue Square Real Estate. Next up, we will put these numbers side by...
TASE:GCT
TASE:GCTReal Estate

G City (TASE:GCT) Net Loss Narrows to 11 Million ILS, Testing Resilience Narrative

G City (TASE:GCT) just posted its Q3 2025 results, reporting revenue of 704 million ILS and a basic EPS of -0.06 ILS. The company has seen revenue ranging from 568 million ILS to 704 million ILS per quarter over the past year, with quarterly EPS consistently in negative territory except for Q2. Margins remain pressured as profitability remains lackluster, giving investors plenty to consider. See our full analysis for G City. Next, we compare these figures with the widely followed narratives...
NasdaqGS:UTHR
NasdaqGS:UTHRBiotechs

Is United Therapeutics Still a Hidden Gem After 34.9% Share Price Surge in 2025?

Wondering if United Therapeutics might be a hidden gem or already fully priced? You are not alone, and the real answer lies deeper than just the current share price. The stock has delivered a robust 34.9% gain year-to-date and climbed an impressive 31.2% over the past 12 months. This signals strong momentum and growing investor confidence. Recent headlines highlight the company’s expanding efforts in pulmonary arterial hypertension treatments and the successful advancement of its organ...
TASE:ISTA
TASE:ISTAHospitality

Issta (TASE:ISTA) Net Profit Margin Drops to 19.3%, Challenging Profitability Narrative

Issta (TASE:ISTA) just posted its Q2 2025 numbers, reporting revenue of ₪111.98 million and EPS of ₪0.35. For context, revenue was ₪93.82 million with EPS of ₪1.37 in Q1 2025, while Q4 2024 saw revenue at ₪109.42 million and EPS of ₪1.63. Margins remained under pressure, painting a mixed picture for investors focused on signs of sustainable profitability. See our full analysis for Issta. Next, we examine the latest results in light of current narratives and market expectations, so you can see...
NasdaqGS:JAMF
NasdaqGS:JAMFSoftware

Assessing Jamf Holding After New Product Launches and 8.2% Year-to-Date Share Price Dip

Ever wondered if Jamf Holding is a hidden gem or a value trap? You are not alone. Many investors are looking for an edge in judging whether this tech stock is priced right. Despite a recent flat patch, with the share price creeping up just 0.5% in the past week and slipping 8.2% year-to-date, big swings in long-term performance could point to shifting sentiment and maybe even new opportunities on the horizon. Jamf has been in the headlines lately with partnerships and new product launches...
NYSE:BLX
NYSE:BLXDiversified Financial

A Look at Bladex (NYSE:BLX) Valuation Following Recent Share Price Growth

Banco Latinoamericano de Comercio Exterior S. A (NYSE:BLX) has delivered a steady month of growth, with its stock price climbing 6% over the past month. Investors are watching to see if this momentum can continue, especially given the bank's focus on trade financing across Latin America and the Caribbean. See our latest analysis for Banco Latinoamericano de Comercio Exterior S. A. Banco Latinoamericano de Comercio Exterior S. A’s 26% share price return so far this year signals a resurgence in...
TASE:NOFR
TASE:NOFRRenewable Energy

Nofar Energy (TASE:NOFR) Q2 Net Loss Deepens, Challenging Optimism Over Profitability Turnaround

O.Y. Nofar Energy (TASE:NOFR) has just posted its Q2 2025 results, reporting revenue of 105.7 million ILS and a basic EPS of -1.34 ILS for the quarter, alongside a net income loss of 47.5 million ILS. Historically, the company’s revenue moved from 101.5 million ILS in Q2 2024 to 105.7 million ILS this quarter. EPS fell from -0.15 ILS to -1.34 ILS over the same periods. Margins continue to be a focal point, with the latest figures highlighting persistent pressure on profitability. See our full...
TSX:FFH
TSX:FFHInsurance

Is Fairfax Financial a Bargain After 470% Five Year Surge and Global Acquisition Push?

Wondering if Fairfax Financial Holdings is fairly priced or a hidden bargain? You are not alone, as many investors are watching closely to see if now is the right time to jump in or hold steady. The stock has delivered a steady 21.7% gain year-to-date, with a 6.8% bump in the last month and an eye-catching 470.0% return over five years, catching the attention of both long-term holders and newcomers. Recent headlines have highlighted Fairfax’s ongoing global acquisitions strategy. The company...
NYSE:QSR
NYSE:QSRHospitality

Is There Value in Restaurant Brands International After Drive-Thru Modernization News?

Wondering if Restaurant Brands International is trading at a bargain or looks overheated? You are not alone; we are diving into what its numbers tell us about value right now. The stock is up 2.7% in the last week and has climbed 9.6% over the past month, which suggests shifting sentiment and renewed interest in its growth story. Headlines have focused on the company’s bold expansion efforts and ongoing brand revamps. Investors hope these changes could propel future sales. The buzz was...
NYSE:RERE
NYSE:RERESpecialty Retail

A Look at ATRenew (NYSE:RERE) Valuation Following Turnaround Profits and Upbeat 2025 Revenue Guidance

ATRenew (NYSE:RERE) just posted third-quarter results showing net income growth and a return to profitability over the past nine months. The company also provided strong revenue guidance for the rest of 2025. This combination is attracting fresh investor attention. See our latest analysis for ATRenew. After a tough stretch earlier in the year, ATRenew's momentum has turned sharply positive. Fresh earnings and robust guidance have helped the stock deliver a 59% share price return year-to-date,...
NYSE:SEM
NYSE:SEMHealthcare

Should Investors Revisit Select Medical Holdings After a 13% Weekly Surge in 2025?

Wondering if Select Medical Holdings is fairly priced, overlooked, or potentially a hidden value? You are not alone, as many investors are eyeing the stock for hints of opportunity. Over the past week, Select Medical has jumped 13.4%, building on an 8.4% gain over the last month, even as it remains down 17.6% year to date. Recent market excitement has been driven by industry-wide discussions about evolving healthcare regulations and strategic partnerships across the sector...
ASX:AX1
ASX:AX1Specialty Retail

Does Accent Group’s (ASX:AX1) Transparent MySale Losses Reveal a New Approach to Cost Discipline?

Earlier this month, Accent Group Limited released updated earnings guidance for the 2026 financial year, forecasting first half EBIT in the A$55 million to A$60 million range and full-year EBIT between A$85 million and A$95 million, accounting for nonrecurring losses from closing its MySale operations. A unique aspect of this update is the explicit inclusion of nonrecurring losses tied to the MySale closure, providing a more transparent view of the company’s operational expectations and cost...